The correlation of 18F-FDG PET/CT metabolic parameters, clinicopathological factors, and prognosis in breast cancer

被引:0
作者
Y.-H. Qu
N. Long
C. Ran
J. Sun
机构
[1] The Affiliated Yantai Yuhuangding Hospital of Qindao University,Department of Medical Imaging
来源
Clinical and Translational Oncology | 2021年 / 23卷
关键词
Breast cancer; F-FDG; PET/CT; Clinicopathological factors; Prognosis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:620 / 627
页数:7
相关论文
共 215 条
  • [1] Siegel RL(2016)Cancer statistics, 2016 CA Cancer J Clin 66 7-30
  • [2] Miller KD(2018)Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 68 394-424
  • [3] Jemal A(2009)NCCN clinical practice guidelines in oncology: breast cancer screening and diagnosis J Natl Compr Cancer Netw 7 1060-1096
  • [4] Bray F(2014)Early assessment with 18F-fluorodeoxyglucose positron emission tomography/computed tomography can help predict the outcome of neoadjuvant chemotherapy in triple negative breast cancer Eur J Cancer 50 1864-1871
  • [5] Ferlay J(2017)Comparative diagnostic accuracy of 18F-FDG PET/CT for breast cancer recurrence Breast Cancer (Dove Med Press) 9 461-471
  • [6] Soerjomataram I(2018)Assessment of biological and clinical aggressiveness of invasive ductal breast cancer using baseline 18F-FDG PET/CT-derived volumetric parameters Nucl Med Commun 39 83-93
  • [7] Siegel RL(2015)Do clinical, histological or immunohistochemical primary tumour characteristics translate into different (18)F-FDG PET/CT volumetric and heterogeneity features in stage II/III breast cancer? Eur J Nucl Med Mol Imaging 42 1682-1691
  • [8] Torre LA(2012)Usefulness of 18F-FDG uptake with clinicopathologic and immunohistochemical prognostic factors in breast cancer Ann Nucl Med 26 175-183
  • [9] Jemal A(2012)Increased FDG uptake in breast cancer is associated with prognostic factors Ann Nucl Med 26 345-350
  • [10] Bevers TB(2011)Correlation of high 18F-FDG uptake to clinical, pathological and biological prognostic factors in breast cancer Eur J Nucl Med Mol Imaging 38 426-435